glp-1 obesity drugs news today 2025 Weight loss on the horizon: STAT's Drug Tracker The next phase of the
Description
doi: 10.2337/db10-0474
M., Gibb, R
Thyroid function: TSH at baseline and periodically
It is important to remember that weight loss is a gradual process, and consistency is key
2019, pp
What are the indications and contraindications for glucagon-like peptide-1 (GLP-1) receptor agonists (e.g., liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide) for weight loss in adults?
